Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2003
11/25/2003US6653515 Synthesis of α, β, β-trifluorostyrene via in-situ formation of trifluorovinyl metal halide
11/25/2003US6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
11/25/2003US6653479 Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride
11/25/2003US6653340 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway
11/25/2003US6653328 3-benzyl-benzothiophenes
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6653034 Stilbeneamine derivative and electrophotosensitive material using the same
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003095445A1 New organic compounds for electroluminescence and organic electroluminescent devices using the same
11/20/2003WO2003095430A1 Substituted pyrazolyl compounds for the treatment of inflammation
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2003050062A3 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216393 Administering to a patient in need an effective pain treating amount of a substituted 1-aminobutan-3-ol compound to treat migraines, hyperalgesia, inflammatory pain, and post-operative pain
11/20/2003US20030216392 Aryl or heteroaryl substituted ethylcarbonylsulfonamide derivatives used as inhibitors of neutrophils chemotaxis and degranulation induced by interleukin 8
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030215738 Comprises arylsulfonyloxime; for integrated circuits
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362854A1 BENZO b]THIOPHENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362382A1 Aryl-aryl dendrimers
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1220848B1 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0766559B1 Cannabinoid receptor antagonists
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212082 Controlling neovascularization; angiogenesis inhibitors; therapy for strokes, cardiovascular disorders; antitumor agents; antidiabetic agents; antiarthritic agents; psoriasis
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212071 Controlling blood coagulation
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030212058 Side effect reduction; osteoporosis therapy
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1359914A2 Novel therapeutic use of a thienylcyclohexylamine derivative
11/12/2003EP1359890A2 Primary intermediates for oxidative coloration of hair
11/12/2003EP1359887A1 Primary intermediates for oxidative coloration of hair
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003CN1455766A Novel 1,2-diphenylethene derivatives for treatment of immune diseases
11/12/2003CN1127493C 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645956 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment
11/11/2003US6645918 N-(Triazolo(1,5-a)pyrimidinyl)thiophenesulfonamide compounds; postemergence herbicides; agriculture
11/06/2003WO2003091675A2 Ultrasonic doppler effect speed measurement
11/06/2003WO2003091240A1 Methylthiophene carboxanilides
11/06/2003WO2003091189A1 Cannabinoids
11/06/2003WO2003090926A1 Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol
11/06/2003WO2003090743A1 Prevention and treatment of functional somatic disorders, including stress-related disorders
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003016270A3 Selective estrogen receptor modulators
11/06/2003WO2003005823A3 Bromonitrothienyldioxans
11/06/2003WO2002083083A3 Pharmaceutically active compounds and methods of use
11/06/2003US20030208067 Inhibitors of protein kinase for the treatment of disease
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207881 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207201 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method
11/06/2003US20030207153 Luminescent device with a triarylamine compound
11/06/2003US20030205701 Highly stable and efficient nonlinear optical chromophores for electro-optic polymers
11/06/2003CA2483093A1 Use of milnacipran or a pharmaceutically acceptable salt thereof for treating chronic low back pain